DNA Copy Number Variations

"DNA Copy Number Variations" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Stretches of genomic DNA that exist in different multiples between individuals. Many copy number variations have been associated with susceptibility or resistance to disease.

Descriptor ID	D056915
MeSH Number(s)	G05.365.795.297.500
Concept/Terms	DNA Copy Number Variations DNA Copy Number Variations DNA Copy Number Variation DNA Copy Number Variants Copy Number Variants, DNA Copy Number Variation, DNA DNA Copy Number Polymorphisms DNA Copy Number Polymorphisms DNA Copy Number Polymorphism Copy Number Polymorphisms Copy Number Polymorphism Polymorphism, Copy Number Polymorphisms, Copy Number DNA Copy Number Changes DNA Copy Number Changes DNA Copy Number Change Copy Number Changes, DNA

Below are MeSH descriptors whose meaning is more general than "DNA Copy Number Variations".

Biological Sciences [G]
Genetic Phenomena [G05]
Genetic Variation [G05.365]
Polymorphism, Genetic [G05.365.795]
Genomic Structural Variation [G05.365.795.297]
DNA Copy Number Variations [G05.365.795.297.500]

Below are MeSH descriptors whose meaning is related to "DNA Copy Number Variations".

Below are MeSH descriptors whose meaning is more specific than "DNA Copy Number Variations".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "DNA Copy Number Variations" by people in this website by year, and whether "DNA Copy Number Variations" was a major or minor topic of these publications.

Bar chart showing 23 publications over 9 distinct years, with a maximum of 6 publications in 2019

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2012	0	1	1
2013	3	1	4
2014	0	3	3
2015	2	1	3
2017	1	1	2
2018	1	0	1
2019	2	4	6
2020	2	0	2
2022	0	1	1

Below are the most recent publications written about "DNA Copy Number Variations" by people in Profiles.

Bowers RR, Jones CM, Paz EA, Barrows JK, Armeson KE, Long DT, Delaney JR. SWAN pathway-network identification of common aneuploidy-based oncogenic drivers. Nucleic Acids Res. 2022 04 22; 50(7):3673-3692.

View in: PubMed
Kumar M, Bowers RR, Delaney JR. Single-cell analysis of copy-number alterations in serous ovarian cancer reveals substantial heterogeneity in both low- and high-grade tumors. Cell Cycle. 2020 11; 19(22):3154-3166.

View in: PubMed
Liu YJ, Houldsworth J, Emmadi R, Dyer L, Wolff DJ. Assessing Genomic Copy Number Alterations as Best Practice for Renal Cell Neoplasia: An Evidence-Based Review from the Cancer Genomics Consortium Workgroup. Cancer Genet. 2020 06; 244:40-54.

View in: PubMed
Wefers AK, Stichel D, Schrimpf D, Coras R, Pages M, Tauziède-Espariat A, Varlet P, Schwarz D, Söylemezoglu F, Pohl U, Pimentel J, Meyer J, Hewer E, Japp A, Joshi A, Reuss DE, Reinhardt A, Sievers P, Casalini MB, Ebrahimi A, Huang K, Koelsche C, Low HL, Rebelo O, Marnoto D, Becker AJ, Staszewski O, Mittelbronn M, Hasselblatt M, Schittenhelm J, Cheesman E, de Oliveira RS, Queiroz RGP, Valera ET, Hans VH, Korshunov A, Olar A, Ligon KL, Pfister SM, Jaunmuktane Z, Brandner S, Tatevossian RG, Ellison DW, Jacques TS, Honavar M, Aronica E, Thom M, Sahm F, von Deimling A, Jones DTW, Blumcke I, Capper D. Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease course. Acta Neuropathol. 2020 01; 139(1):193-209.

View in: PubMed
Norton PA, Mehta AS. Expression of genes that control core fucosylation in hepatocellular carcinoma: Systematic review. World J Gastroenterol. 2019 Jun 21; 25(23):2947-2960.

View in: PubMed
Mikhail FM, Biegel JA, Cooley LD, Dubuc AM, Hirsch B, Horner VL, Newman S, Shao L, Wolff DJ, Raca G. Technical laboratory standards for interpretation and reporting of acquired copy-number abnormalities and copy-neutral loss of heterozygosity in neoplastic disorders: a joint consensus recommendation from the American College of Medical Genetics and Genomics (ACMG) and the Cancer Genomics Consortium (CGC). Genet Med. 2019 09; 21(9):1903-1916.

View in: PubMed
Casanova EL, Switala AE, Dandamudi S, Hickman AR, Vandenbrink J, Sharp JL, Feltus FA, Casanova MF. Autism risk genes are evolutionarily ancient and maintain a unique feature landscape that echoes their function. Autism Res. 2019 06; 12(6):860-869.

View in: PubMed
Sonpavde G, Agarwal N, Pond GR, Nagy RJ, Nussenzveig RH, Hahn AW, Sartor O, Gourdin TS, Nandagopal L, Ledet EM, Naik G, Armstrong AJ, Wang J, Bilen MA, Gupta S, Grivas P, Pal SK, Lanman RB, Talasaz A, Lilly MB. Circulating tumor DNA alterations in patients with metastatic castration-resistant prostate cancer. Cancer. 2019 05 01; 125(9):1459-1469.

View in: PubMed
Rowsey R, Znoyko I, Wolff DJ. Whole-Genome Single Nucleotide Polymorphism Microarray for Copy Number and Loss of Heterozygosity Analysis in Tumors. Methods Mol Biol. 2019; 1908:89-111.

View in: PubMed
Chun K, Wenger GD, Chaubey A, Dash DP, Kanagal-Shamanna R, Kantarci S, Kolhe R, Van Dyke DL, Wang L, Wolff DJ, Miron PM. Assessing copy number aberrations and copy-neutral loss-of-heterozygosity across the genome as best practice: An evidence-based review from the Cancer Genomics Consortium (CGC) working group for chronic lymphocytic leukemia. Cancer Genet. 2018 12; 228-229:236-250.

View in: PubMed

People

Explore

Similar Concepts

Top Journals